Gujarat Themis Biosyn Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 8th May, 2023, intimating you about the earning conference call for Q4 & FY23 with Analysts/Investors held on 15th May, 2023, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at www.gtbl.in

pdf

Gujarat Themis Biosyn Ltd.

15 May 2023

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Audio Recording Of The Earnings Conference Call For Q4 …

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on Monday, May 15, 2023, for the quarter and year ended March 31, 2023, has been uploaded on the website of the Company at http://www.gtbl.in/wp-content/uploads/2023/05/Concall-dated-15.05.2023.mp3

pdf

Gujarat Themis Biosyn Ltd.

15 Feb 2023

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company had a meeting with Analysts/Investors on Tuesday, 14th February 2023; the details of the same are given below: Sr. no. Date Name Venue 1 14th February 2023 Taiyo Pacific Partners Mumbai No Unpublished Price Sensitive Information (UPSI) was discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

pdf

Gujarat Themis Biosyn Ltd.

09 Feb 2023

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 31st January, 2023, intimating you about the earning conference call for Q3 & 9M FY23 with Analysts/Investors held on 6th February, 2023, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at www.gtbl.in Kindly take the same on record.

pdf

Gujarat Themis Biosyn Ltd.

06 Feb 2023

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Audio Recording Of The Earnings Conference Call For Q3 …

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on February 6, 2023, for the quarter ended December 31, 2022, has been uploaded on the website of the Company at http://www.gtbl.in/wp-content/uploads/2023/02/Concall-Gujarat-Themis-Biosyn-Limited-06-02-2023.mp3

pdf

Gujarat Themis Biosyn Ltd.

01 Dec 2022

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company had meetings with Analysts/Investors on Thursday, 1st December 2022; the details of the same are given below: Sr. no. Date Name Venue 1 1st December 2022 Patni Financial Advisors Mumbai 2 Molecule Ventures No Unpublished Price Sensitive Information (UPSI) was discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

pdf

Gujarat Themis Biosyn Ltd.

30 Nov 2022

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company had meetings with Analysts/Investors on Wednesday, 30th November 2022; the details of the same are given below: Sr. no. Date Name Venue 1 30th November 2022 Kotak Securities Mumbai 2 Systematix Group 3 Moneybee Advisors 4 Sequent Investments 5 Ashmavir Financial Consultants No Unpublished Price Sensitive Information (UPSI) was discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

pdf

Gujarat Themis Biosyn Ltd.

21 Nov 2022

263.75

7.41%

Earnings Call

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 7th November, 2022, intimating you about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at www.gtbl.in

pdf

Gujarat Themis Biosyn Ltd. Conference Calls and Earnings Call Transcripts